Stay updated on Safety Efficacy of Rituximab & Pembrolizumab in Waldenström's Clinical Trial
Sign up to get notified when there's something new on the Safety Efficacy of Rituximab & Pembrolizumab in Waldenström's Clinical Trial page.

Latest updates to the Safety Efficacy of Rituximab & Pembrolizumab in Waldenström's Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now shows a new revision banner 'Revision: v3.4.2' and removes older funding/operating notices. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the page revision to v3.4.1; removed the previous v3.4.0 revision. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a glossary toggle, updated the QC status to 'Last Update Submitted that Met QC Criteria', and added 'No FEAR Act Data' and 'Revision: v3.4.0'. Removed the previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 is now displayed in the page footer, replacing v3.3.3, indicating a minor site version update with no changes to the study details or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedLocation sections were updated: new locations Devon, Dorset, Greater London, Greater Manchester, and Oxfordshire were added, and the corresponding location subsections were removed, with the page revision updated to v3.3.3.SummaryDifference0.6%

- Check85 days agoChange DetectedThe page now shows Revision: v3.3.2 replacing Revision: v3.3.1, a minor metadata update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Safety Efficacy of Rituximab & Pembrolizumab in Waldenström's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Efficacy of Rituximab & Pembrolizumab in Waldenström's Clinical Trial page.